The FDA Oct. 4 issued a final rule to establish requirements for the medical device de novo classification process, through which some products may obtain market authorization as Class I or Class II devices. The requirements in the final rule “are intended to ensure the most appropriate classification of devices consistent with the protection of the public health and the stat... Read More